RNA logo

Avidity Biosciences (RNA) Long term liabilities

Annual long term liabilities:

$40.92M-$6.19M(-13.15%)
December 31, 2024

Summary

  • As of today (June 1, 2025), RNA annual total long term liabilities is $40.92 million, with the most recent change of -$6.19 million (-13.15%) on December 31, 2024.
  • During the last 3 years, RNA annual long term liabilities has risen by +$24.43 million (+148.11%).
  • RNA annual long term liabilities is now -73.09% below its all-time high of $152.03 million, reached on December 31, 2019.

Performance

RNA Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRNAbalance sheet metrics

quarterly long term liabilities:

$45.49M+$4.57M(+11.17%)
March 31, 2025

Summary

  • As of today (June 1, 2025), RNA quarterly total long term liabilities is $45.49 million, with the most recent change of +$4.57 million (+11.17%) on March 31, 2025.
  • Over the past year, RNA quarterly long term liabilities has dropped by -$133.00 thousand (-0.29%).
  • RNA quarterly long term liabilities is now -70.08% below its all-time high of $152.03 million, reached on December 31, 2019.

Performance

RNA quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRNAbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RNA Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.2%-0.3%
3 y3 years+148.1%+213.6%
5 y5 years-73.1%+196.6%

RNA Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-13.2%+364.1%-3.5%+615.0%
5 y5-year-73.1%+364.1%-3.5%+615.0%
alltimeall time-73.1%+364.1%-70.1%+615.0%

RNA Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$45.49M(+11.2%)
Dec 2024
$40.92M(-13.1%)
$40.92M(-11.2%)
Sep 2024
-
$46.06M(+9.2%)
Jun 2024
-
$42.18M(-7.5%)
Mar 2024
-
$45.62M(-3.2%)
Dec 2023
$47.11M(+434.3%)
$47.11M(+575.0%)
Sep 2023
-
$6.98M(+9.7%)
Jun 2023
-
$6.36M(-8.8%)
Mar 2023
-
$6.98M(-20.9%)
Dec 2022
$8.82M
$8.82M(-19.0%)
Sep 2022
-
$10.89M(-14.7%)
DateAnnualQuarterly
Jun 2022
-
$12.76M(-12.0%)
Mar 2022
-
$14.51M(-12.0%)
Dec 2021
$16.49M(+26.0%)
$16.49M(+91.3%)
Sep 2021
-
$8.62M(-11.2%)
Jun 2021
-
$9.71M(-12.7%)
Mar 2021
-
$11.12M(-15.0%)
Dec 2020
$13.09M(-91.4%)
$13.09M(+6.5%)
Sep 2020
-
$12.29M(-8.6%)
Jun 2020
-
$13.44M(-12.4%)
Mar 2020
-
$15.34M(-89.9%)
Dec 2019
$152.03M(+275.4%)
$152.03M
Dec 2018
$40.49M
-

FAQ

  • What is Avidity Biosciences annual total long term liabilities?
  • What is the all time high annual long term liabilities for Avidity Biosciences?
  • What is Avidity Biosciences annual long term liabilities year-on-year change?
  • What is Avidity Biosciences quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Avidity Biosciences?
  • What is Avidity Biosciences quarterly long term liabilities year-on-year change?

What is Avidity Biosciences annual total long term liabilities?

The current annual long term liabilities of RNA is $40.92M

What is the all time high annual long term liabilities for Avidity Biosciences?

Avidity Biosciences all-time high annual total long term liabilities is $152.03M

What is Avidity Biosciences annual long term liabilities year-on-year change?

Over the past year, RNA annual total long term liabilities has changed by -$6.19M (-13.15%)

What is Avidity Biosciences quarterly total long term liabilities?

The current quarterly long term liabilities of RNA is $45.49M

What is the all time high quarterly long term liabilities for Avidity Biosciences?

Avidity Biosciences all-time high quarterly total long term liabilities is $152.03M

What is Avidity Biosciences quarterly long term liabilities year-on-year change?

Over the past year, RNA quarterly total long term liabilities has changed by -$133.00K (-0.29%)
On this page